ANK1
Basic information
Region (hg38): 8:41653220-41896741
Previous symbols: [ "ANK" ]
Links
Phenotypes
GenCC
Source:
- hereditary spherocytosis type 1 (Strong), mode of inheritance: AD
- hereditary spherocytosis (Supportive), mode of inheritance: AD
- hereditary spherocytosis type 1 (Strong), mode of inheritance: AD
- hereditary spherocytosis type 1 (Limited), mode of inheritance: AR
- hereditary spherocytosis (Limited), mode of inheritance: AR
- hereditary spherocytosis (Definitive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Spherocytosis, type 1 | AD/AR | Hematologic | Some individuals may have therapy requiring neonatal hyperbilirubinemia, as well as severe, transfusion-requiring anemia | Hematologic | 14467968; 4476391; 2675425; 1832935; 1486040; 8640229; 9887280; 9430667; 17327413; 20512576; 32436265 |
ClinVar
This is a list of variants' phenotypes submitted to
- Hereditary spherocytosis type 1 (64 variants)
- not provided (57 variants)
- ANK1-related disorder (8 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ANK1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 27 | 103 | 10 | 140 | ||
missense | 308 | 11 | 324 | |||
nonsense | 47 | 34 | 81 | |||
start loss | 1 | |||||
frameshift | 53 | 81 | 137 | |||
inframe indel | 2 | |||||
splice donor/acceptor (+/-2bp) | 12 | 39 | 53 | |||
splice region | 16 | 11 | 2 | 29 | ||
non coding | 62 | 37 | 87 | 189 | ||
Total | 114 | 159 | 404 | 151 | 99 |
Highest pathogenic variant AF is 0.00000657
Variants in ANK1
This is a list of pathogenic ClinVar variants found in the ANK1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
8-41653381-G-A | Spherocytosis • Hereditary spherocytosis type 1 | Uncertain significance (Jan 13, 2018) | ||
8-41653448-G-C | Hereditary spherocytosis type 1 • Spherocytosis | Uncertain significance (Jan 13, 2018) | ||
8-41653509-G-A | Hereditary spherocytosis type 1 • Spherocytosis | Uncertain significance (Jan 13, 2018) | ||
8-41653518-G-C | Uncertain significance (Jan 15, 2021) | |||
8-41653618-G-T | Hereditary spherocytosis type 1 • Spherocytosis | Uncertain significance (Jan 12, 2018) | ||
8-41653638-A-C | Hereditary spherocytosis type 1 • Spherocytosis | Benign (Jan 13, 2018) | ||
8-41653667-C-A | Hereditary spherocytosis type 1 • Spherocytosis | Uncertain significance (Jan 12, 2018) | ||
8-41653768-C-T | Hereditary spherocytosis type 1 • Spherocytosis | Benign/Likely benign (Jan 13, 2018) | ||
8-41653838-C-T | Hereditary spherocytosis type 1 • Spherocytosis | Uncertain significance (Jan 12, 2018) | ||
8-41653891-C-T | Hereditary spherocytosis type 1 • Spherocytosis | Benign/Likely benign (Jan 12, 2018) | ||
8-41653898-C-A | Spherocytosis • Hereditary spherocytosis type 1 | Uncertain significance (Jan 12, 2018) | ||
8-41653898-C-T | Spherocytosis • Hereditary spherocytosis type 1 | Conflicting classifications of pathogenicity (Jan 13, 2018) | ||
8-41653906-C-T | Hereditary spherocytosis type 1 • Spherocytosis | Uncertain significance (Jan 13, 2018) | ||
8-41653910-G-T | Spherocytosis • Hereditary spherocytosis type 1 | Uncertain significance (Jan 12, 2018) | ||
8-41653932-T-G | Spherocytosis • Hereditary spherocytosis type 1 | Uncertain significance (Jan 12, 2018) | ||
8-41653982-T-C | Hereditary spherocytosis type 1 • Spherocytosis | Uncertain significance (Jan 13, 2018) | ||
8-41654082-C-G | Hereditary spherocytosis type 1 • Spherocytosis | Conflicting classifications of pathogenicity (Apr 01, 2023) | ||
8-41654123-A-T | Hereditary spherocytosis type 1 | Likely benign (Apr 27, 2017) | ||
8-41654181-G-C | Hereditary spherocytosis type 1 • Spherocytosis | Benign/Likely benign (Jan 13, 2018) | ||
8-41654187-G-C | Spherocytosis • Hereditary spherocytosis type 1 | Uncertain significance (Jan 12, 2018) | ||
8-41654200-C-T | Hereditary spherocytosis type 1 • Spherocytosis | Uncertain significance (Jan 13, 2018) | ||
8-41654316-G-A | Spherocytosis • Hereditary spherocytosis type 1 | Uncertain significance (Jan 12, 2018) | ||
8-41654366-G-A | Spherocytosis • Hereditary spherocytosis type 1 | Uncertain significance (Jan 12, 2018) | ||
8-41654378-C-T | Hereditary spherocytosis type 1 • Spherocytosis | Uncertain significance (Jan 13, 2018) | ||
8-41654388-C-A | Hereditary spherocytosis type 1 • Spherocytosis | Conflicting classifications of pathogenicity (Jan 12, 2018) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ANK1 | protein_coding | protein_coding | ENST00000265709 | 43 | 243542 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 4.23e-9 | 125584 | 0 | 164 | 125748 | 0.000652 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.08 | 927 | 1.12e+3 | 0.825 | 0.0000764 | 12316 |
Missense in Polyphen | 354 | 506.3 | 0.69919 | 5445 | ||
Synonymous | -0.648 | 502 | 484 | 1.04 | 0.0000361 | 3884 |
Loss of Function | 8.06 | 9 | 92.8 | 0.0970 | 0.00000505 | 1064 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00307 | 0.00298 |
Ashkenazi Jewish | 0.000299 | 0.000298 |
East Asian | 0.000438 | 0.000435 |
Finnish | 0.00121 | 0.00120 |
European (Non-Finnish) | 0.000612 | 0.000607 |
Middle Eastern | 0.000438 | 0.000435 |
South Asian | 0.00 | 0.00 |
Other | 0.00115 | 0.00114 |
dbNSFP
Source:
- Function
- FUNCTION: Attaches integral membrane proteins to cytoskeletal elements; binds to the erythrocyte membrane protein band 4.2, to Na-K ATPase, to the lymphocyte membrane protein GP85, and to the cytoskeletal proteins fodrin, tubulin, vimentin and desmin. Erythrocyte ankyrins also link spectrin (beta chain) to the cytoplasmic domain of the erythrocytes anion exchange protein; they retain most or all of these binding functions. {ECO:0000269|PubMed:12456646}.;
- Disease
- DISEASE: Spherocytosis 1 (SPH1) [MIM:182900]: A form of spherocytosis, a hematologic disorder leading to chronic hemolytic anemia and characterized by numerous abnormally shaped erythrocytes which are generally spheroidal. SPH1 is characterized by severe hemolytic anemia. Inheritance can be autosomal dominant or autosomal recessive. Patients with homozygous mutations have a more severe disorder. {ECO:0000269|PubMed:11102985, ECO:0000269|PubMed:8640229}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Proteoglycans in cancer - Homo sapiens (human);Developmental Biology;Vesicle-mediated transport;Membrane Trafficking;Post-translational protein modification;Metabolism of proteins;NrCAM interactions;CHL1 interactions;Neurofascin interactions;Transport to the Golgi and subsequent modification;Asparagine N-linked glycosylation;Interaction between L1 and Ankyrins;L1CAM interactions;COPI-mediated anterograde transport;Axon guidance;ER to Golgi Anterograde Transport
(Consensus)
Recessive Scores
- pRec
- 0.748
Intolerance Scores
- loftool
- 0.109
- rvis_EVS
- -3.14
- rvis_percentile_EVS
- 0.45
Haploinsufficiency Scores
- pHI
- 0.753
- hipred
- Y
- hipred_score
- 0.825
- ghis
- 0.547
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.968
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ank1
- Phenotype
- liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); pigmentation phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); immune system phenotype; skeleton phenotype; renal/urinary system phenotype; integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; endocrine/exocrine gland phenotype; muscle phenotype; homeostasis/metabolism phenotype;
Gene ontology
- Biological process
- exocytosis;endoplasmic reticulum to Golgi vesicle-mediated transport;cytoskeleton organization;signal transduction;positive regulation of organelle organization;maintenance of epithelial cell apical/basal polarity;protein localization to plasma membrane
- Cellular component
- nucleus;cytosol;cytoskeleton;plasma membrane;cytoplasmic side of plasma membrane;spectrin-associated cytoskeleton;membrane;basolateral plasma membrane;sarcoplasmic reticulum;Z disc;axolemma;M band;sarcolemma;axon initial segment;postsynaptic membrane
- Molecular function
- structural molecule activity;structural constituent of cytoskeleton;protein binding;cytoskeletal adaptor activity;enzyme binding;protein phosphatase binding;spectrin binding;ion channel binding;ATPase binding